/
/
/

CORONA Remedies Balance Sheet

Consolidated
Standalone
%

Share Price Live Stats

Open (₹)2,208.20
Volume (₹)3.55 L
High (₹)2,225.00
Upper Circuit2,636.60
Low (₹)2,060.50
Lower Circuit1,757.80
Prev Close2,197.20
52W High (₹)2,270.10
Price2,200.80
52W Low (₹)1,336.60

Share Market Cap & Key Ratios Overview

M.Cap (₹)13389.80 Cr
Div. Yield (%)0.46
PE Ratio67.28
Debt to Equity0.19
Price to Book12.74
Book Value122.12
EPS (TTM)32.54
Face Value10.00
ROE (%)27.36

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
AUROPHARMANSE
LUPINNSE
DRREDDYNSE
MANKINDNSE
CORONANSE
LTP
1W Low
1W High
Market cap (₹)
1861-38 (-2.00%)
1840.50
1907.80
4,48,316Cr
9438.5+338.5 (3.72%)
9119.50
9615
2,51,737Cr
4930+73 (1.50%)
4823
5000
1,87,594Cr
1117.8-2.2 (-0.20%)
1108.10
1167.70
1,12,618Cr
1373.3-11.7 (-0.84%)
1363.10
1398.40
1,10,515Cr
1945+105 (5.71%)
1832.70
1955
1,04,456Cr
1668.4+15.3 (0.93%)
1646
1704
97,239Cr
2077.8-32.2 (-1.53%)
2060.30
2135.50
95,660Cr
1143-8 (-0.70%)
1134.90
1163.20
95,421Cr
2238.4-89.5 (-3.84%)
2235.10
2331.60
93,596Cr
2200.8+100.7 (4.80%)
2054.80
2246.90
13,390Cr

Key Highlights of CORONA Remedies Ltd Balance Sheet

CORONA Remedies Ltd balance sheet discloses shareholders' funds of ₹61.16Cr as of 2026-03-31. The company’s equity share capital is at a value of ₹61.16Cr, and the reserves and surplus of the company is ₹684.81Cr.

The company has its non-current liabilities with total liabilities of ₹1297.61Cr as of 2026-03-31.

The current liabilities are ₹454.53Cr as of 2026-03-31. At the same time, current assets are ₹441.67Cr as of 2026-03-31.

Key assets on the balance sheet are non-current investments of ₹25.4Cr and tangible assets of ₹553.97Cr, provided in the CORONA Remedies Ltd financial statements.